These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 9527304)

  • 21. Aminorex to Fen/Phen: an epidemic foretold.
    Tellier P
    Circulation; 1999 Dec; 100(25):e146; author reply e147. PubMed ID: 10604912
    [No Abstract]   [Full Text] [Related]  

  • 22. Fenfluramine and phentermine.
    Shuster J
    Nursing; 1997 Feb; 27(2):69. PubMed ID: 9171612
    [No Abstract]   [Full Text] [Related]  

  • 23. Further cases of valvular heart disease associated with fenfluramine-phentermine.
    Graham DJ; Green L
    N Engl J Med; 1997 Aug; 337(9):635. PubMed ID: 9280830
    [No Abstract]   [Full Text] [Related]  

  • 24. Severe heart valve disease on appetite suppressants.
    Prescrire Int; 1998 Feb; 7(33):19-20. PubMed ID: 10183395
    [No Abstract]   [Full Text] [Related]  

  • 25. [Drug-clinics. The hue and cry over central appetite suppressants!].
    Scheen AJ
    Rev Med Liege; 1997 Sep; 52(9):613-5. PubMed ID: 9441348
    [No Abstract]   [Full Text] [Related]  

  • 26. Cerebral hemorrhage in a patient taking fenfluramine and phentermine for obesity.
    Wen PY; Feske SK; Teoh SK; Stieg PE
    Neurology; 1997 Aug; 49(2):632-3. PubMed ID: 9270617
    [No Abstract]   [Full Text] [Related]  

  • 27. Fenfluramine: riddle or Rosetta stone?
    Weir EK; Obreztchikova M; Hong Z
    Eur Respir J; 2008 Feb; 31(2):232-5. PubMed ID: 18238944
    [No Abstract]   [Full Text] [Related]  

  • 28. Complex vascular lesions at autopsy in a patient with phentermine-fenfluramin.
    Widgren S
    Arch Pathol Lab Med; 2000 Jun; 124(6):801-2. PubMed ID: 10835505
    [No Abstract]   [Full Text] [Related]  

  • 29. Valvular heart disease associated with fenfluramine-phentermine.
    Spitzer WO
    N Engl J Med; 1997 Dec; 337(24):1774-5; author reply 1775-6. PubMed ID: 9411251
    [No Abstract]   [Full Text] [Related]  

  • 30. Synergistic interactions between fenfluramine and phentermine.
    Wellman PJ; Maher TJ
    Int J Obes Relat Metab Disord; 1999 Jul; 23(7):723-32. PubMed ID: 10454106
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Report links appetite suppressants with heart disease. FDA encourages reporting of like events.
    Am J Health Syst Pharm; 1997 Aug; 54(16):1785, 1788. PubMed ID: 9269513
    [No Abstract]   [Full Text] [Related]  

  • 32. Regression of multivalvular regurgitation after the cessation of fenfluramine and phentermine treatment.
    Cannistra LB; Cannistra AJ
    N Engl J Med; 1998 Sep; 339(11):771. PubMed ID: 9742026
    [No Abstract]   [Full Text] [Related]  

  • 33. After fen-phen/Redux: cardiac and pulmonary sequelae implications for patient assessment.
    Brown-Beasley MW
    J Emerg Nurs; 1998 Feb; 24(1):62-5. PubMed ID: 9534536
    [No Abstract]   [Full Text] [Related]  

  • 34. Anorectic therapy and valvular heart disease: a reappraisal.
    Silvestry FE; St John Sutton M
    Eur Heart J; 1999 Jul; 20(13):917-20. PubMed ID: 10361039
    [No Abstract]   [Full Text] [Related]  

  • 35. Fen-phen's message to dentists.
    Hilsen K; Davis S; Iyer P
    J N J Dent Assoc; 1998; 69(1):37, 47. PubMed ID: 9584764
    [No Abstract]   [Full Text] [Related]  

  • 36. Comparison of combinations of drugs for treatment of obesity: body weight and echocardiographic status.
    Whigham LD; Dhurandhar NV; Rahko PS; Atkinson RL
    Int J Obes (Lond); 2007 May; 31(5):850-7. PubMed ID: 17146452
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Valvular heart disease in fenfluramine- phentermine-treated patients: a comparison with control patients.
    Wadden TA; Silvestry FE; Aber JL; Berkowitz RI; Foster GD; Sutton MG
    Obes Res; 1999 May; 7(3):309-10. PubMed ID: 10348504
    [No Abstract]   [Full Text] [Related]  

  • 38. In search of a 'magic' pill to treat obesity: the rise and fall of 'Fen-Phen'.
    Capriotti T
    Medsurg Nurs; 1998 Feb; 7(1):52-4. PubMed ID: 9544011
    [No Abstract]   [Full Text] [Related]  

  • 39. Appetite suppressants and valvular heart disease.
    Devereux RB
    N Engl J Med; 1998 Sep; 339(11):765-6. PubMed ID: 9731094
    [No Abstract]   [Full Text] [Related]  

  • 40. Diet drug-related cardiac valve disease: the Mayo Clinic echocardiographic laboratory experience.
    Teramae CY; Connolly HM; Grogan M; Miller FA
    Mayo Clin Proc; 2000 May; 75(5):456-61. PubMed ID: 10807073
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.